These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 25171752)
1. N-(4-[(18)F]-fluoropyridin-2-yl)-N-{2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl}carboxamides as analogs of WAY100635. New PET tracers of serotonin 5-HT(1A) receptors. García G; Abet V; Alajarín R; Álvarez-Builla J; Delgado M; García-García L; Bascuñana-Almarcha P; Peña-Salcedo C; Kelly J; Pozo MA Eur J Med Chem; 2014 Oct; 85():795-806. PubMed ID: 25171752 [TBL] [Abstract][Full Text] [Related]
2. PET imaging of brain 5-HT1A receptors in rat in vivo with 18F-FCWAY and improvement by successful inhibition of radioligand defluorination with miconazole. Tipre DN; Zoghbi SS; Liow JS; Green MV; Seidel J; Ichise M; Innis RB; Pike VW J Nucl Med; 2006 Feb; 47(2):345-53. PubMed ID: 16455642 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and in vitro evaluation of bridgehead fluoromethyl analogs of N-{2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl}-N-(pyridin-2-yl)cyclohexanecarboxamide (WAY-100635) for the 5-HT(1A) receptor. Al Hussainy R; Verbeek J; van der Born D; Booij J; Herscheid JK Eur J Med Chem; 2011 Dec; 46(12):5728-35. PubMed ID: 22000209 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and biologic evaluation of a novel serotonin 5-HT1A receptor radioligand, 18F-labeled mefway, in rodents and imaging by PET in a nonhuman primate. Saigal N; Pichika R; Easwaramoorthy B; Collins D; Christian BT; Shi B; Narayanan TK; Potkin SG; Mukherjee J J Nucl Med; 2006 Oct; 47(10):1697-706. PubMed ID: 17015907 [TBL] [Abstract][Full Text] [Related]
5. First-in-human evaluation of 18F-mefway, a PET radioligand specific to serotonin-1A receptors. Hillmer AT; Wooten DW; Bajwa AK; Higgins AT; Lao PJ; Betthauser TJ; Barnhart TE; Rowley HA; Stone CK; Johnson SC; Mukherjee J; Christian BT J Nucl Med; 2014 Dec; 55(12):1973-9. PubMed ID: 25453045 [TBL] [Abstract][Full Text] [Related]
6. Disulfiram inhibits defluorination of (18)F-FCWAY, reduces bone radioactivity, and enhances visualization of radioligand binding to serotonin 5-HT1A receptors in human brain. Ryu YH; Liow JS; Zoghbi S; Fujita M; Collins J; Tipre D; Sangare J; Hong J; Pike VW; Innis RB J Nucl Med; 2007 Jul; 48(7):1154-61. PubMed ID: 17574977 [TBL] [Abstract][Full Text] [Related]
7. Comparison of 4 radiolabeled antagonists for serotonin 5-HT(7) receptor neuroimaging: toward the first PET radiotracer. Lemoine L; Andries J; Le Bars D; Billard T; Zimmer L J Nucl Med; 2011 Nov; 52(11):1811-8. PubMed ID: 21990574 [TBL] [Abstract][Full Text] [Related]
8. Radiosynthesis and preclinical evaluation of 18F-F13714 as a fluorinated 5-HT1A receptor agonist radioligand for PET neuroimaging. Lemoine L; Becker G; Vacher B; Billard T; Lancelot S; Newman-Tancredi A; Zimmer L J Nucl Med; 2012 Jun; 53(6):969-76. PubMed ID: 22577236 [TBL] [Abstract][Full Text] [Related]
9. 18F-Mefway PET imaging of serotonin 1A receptors in humans: a comparison with 18F-FCWAY. Choi JY; Lyoo CH; Kim JS; Kim KM; Kang JH; Choi SH; Kim JJ; Ryu YH PLoS One; 2015; 10(4):e0121342. PubMed ID: 25830772 [TBL] [Abstract][Full Text] [Related]
10. The pyridinyl-6 position of WAY-100635 as a site for radiofluorination--effect on 5-HT1A receptor radioligand behavior in vivo. McCarron JA; Pike VW; Halldin C; Sandell J; Sóvágó J; Gulyas B; Cselényi Z; Wikström HV; Marchais-Oberwinkler S; Nowicki B; Dollé F; Farde L Mol Imaging Biol; 2004; 6(1):17-26. PubMed ID: 15018825 [TBL] [Abstract][Full Text] [Related]
11. Isoindol-1-one analogues of 4-(2'-methoxyphenyl)-1-[2'-[N-(2"-pyridyl)-p-iodobenzamido]ethyl]pipera zine (p-MPPI) as 5-HT1A receptor ligands. Zhuang ZP; Kung MP; Mu M; Kung HF J Med Chem; 1998 Jan; 41(2):157-66. PubMed ID: 9457239 [TBL] [Abstract][Full Text] [Related]
13. [18F]F15599, a novel 5-HT1A receptor agonist, as a radioligand for PET neuroimaging. Lemoine L; Verdurand M; Vacher B; Blanc E; Le Bars D; Newman-Tancredi A; Zimmer L Eur J Nucl Med Mol Imaging; 2010 Mar; 37(3):594-605. PubMed ID: 19789870 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and in vivo biodistribution of F-18 labeled 3-cis-, 3-trans-, 4-cis-, and 4-trans-fluorocyclohexane derivatives of WAY 100635. Lang L; Jagoda E; Ma Y; Sassaman MB; Eckelman WC Bioorg Med Chem; 2006 Jun; 14(11):3737-48. PubMed ID: 16488611 [TBL] [Abstract][Full Text] [Related]
16. Marmoset Serotonin 5-HT1A Receptor Mapping with a Biased Agonist PET Probe 18F-F13714: Comparison with an Antagonist Tracer 18F-MPPF in Awake and Anesthetized States. Yokoyama C; Mawatari A; Kawasaki A; Takeda C; Onoe K; Doi H; Newman-Tancredi A; Zimmer L; Onoe H Int J Neuropsychopharmacol; 2016 Dec; 19(12):. PubMed ID: 27608810 [TBL] [Abstract][Full Text] [Related]
17. Radiochemical synthesis and tissue distribution of p-[18F]DMPPF, a new 5-HT1A ligand for PET, in rats. Defraiteur C; Lemaire C; Luxen A; Plenevaux A Nucl Med Biol; 2006 Jul; 33(5):667-75. PubMed ID: 16843842 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and initial evaluation of [11C](R)-RWAY in monkey-a new, simply labeled antagonist radioligand for imaging brain 5-HT1A receptors with PET. McCarron JA; Zoghbi SS; Shetty HU; Vermeulen ES; Wikström HV; Ichise M; Yasuno F; Halldin C; Innis RB; Pike VW Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1670-82. PubMed ID: 17579853 [TBL] [Abstract][Full Text] [Related]